REMISSION INDUCTION IN NON-HODGKIN LYMPHOMA WITH RESHAPED HUMAN MONOCLONAL ANTIBODY CAMPATH-1H
- 1 December 1988
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 332 (8625) , 1394-1399
- https://doi.org/10.1016/s0140-6736(88)90588-0
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q.The Journal of Experimental Medicine, 1988
- T CELL DEPLETION WITH CAMPATH-1 IN ALLOGENEIC BONE MARROW TRANSPLANTATIONTransplantation, 1988
- Reshaping human antibodies for therapyNature, 1988
- Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies.The Journal of Experimental Medicine, 1987
- Isolation of low-frequency class-switch variants from rat hybrid myelomásJournal of Immunological Methods, 1987
- Reactivity of rat monoclonal antibody CAMPATH‐1 with human leukaemia cells and its possible application for autologous bone marrow transplantationBritish Journal of Haematology, 1985
- ELIMINATION OF GRAFT-VERSUS-HOST DISEASE BY IN-VITRO DEPLETION OF ALLOREACTIVE LYMPHOCYTES WITH A MONOCLONAL RAT ANTI-HUMAN LYMPHOCYTE ANTIBODY (CAMPATH-1)The Lancet, 1984
- Biological and Clinical Implications of Lymphocyte Hybridomas: Tumor Therapy with Monoclonal AntibodiesAnnual Review of Medicine, 1983
- Eighty years of immunotherapy: a review of immunological methods used for the treatment of human cancerBritish Journal of Cancer, 1972
- Metabolic properties of IgG subclasses in manJournal of Clinical Investigation, 1970